Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

10

Actual shortage: 5 (50%)
Anticipated shortage: 2 (20%)
Avoided shortage: 0 (0%)
Resolved: 3 (30%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (10%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Last updated Reports
NAT-QUETIAPINE 25MG TABLET Actual shortage 2018-10-31 2018-10-31 65944
NAT-DONEPEZIL 5MG TABLET Actual shortage 2018-07-13 2018-07-14 55625
NAT-DONEPEZIL 10MG TABLET Actual shortage 2018-07-13 2018-07-14 55630
NAT-LEVETIRACETAM 250MG TABLET Actual shortage 2019-02-15 2019-02-16 75810
NAT-LEVETIRACETAM 500MG TABLET Actual shortage 2018-10-19 2019-02-15 64878
NAT-ESCITALOPRAM 10MG TABLET Anticipated shortage 2019-02-15 2019-02-15 75793
NAT-ESCITALOPRAM 20MG TABLET Anticipated shortage 2019-02-15 2019-02-15 75799
NAT-CITALOPRAM 10MG TABLET Resolved 2018-11-23 2019-02-04 67518
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67512
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67515
Discontinuation reports
Brand name Strength Dosage Status Date Created Last updated Reports